DENTSPLY SIRONA Profit Margin 2006-2019 | XRAY
Current and historical gross margin, operating margin and net profit margin for DENTSPLY SIRONA (XRAY) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. DENTSPLY SIRONA net profit margin as of September 30, 2019 is 4.08%.
| DENTSPLY SIRONA Annual Profit Margins |
|---|
| DENTSPLY SIRONA Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $12.911B | $3.986B |
| DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. The Company's products include dental prosthetics, endodontic instruments, dental sealants, ultrasonic scalers, dental x-ray equipment and intraoral cameras. DENTSPLY SIRONA Inc., formerly known as DENTSPLY International Inc., is based in United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Becton Dickinson (BDX) | United States | $70.506B | 22.32 |
| McKesson (MCK) | United States | $25.635B | 10.16 |
| Align Technology (ALGN) | United States | $21.730B | 59.55 |
| AmerisourceBergen (ABC) | United States | $18.171B | 12.46 |
| Laboratory Of America Holdings (LH) | United States | $16.670B | 15.65 |
| Cardinal Health (CAH) | United States | $16.049B | 10.43 |
| Straumann Holding AG (SAUHF) | Switzerland | $15.257B | 0.00 |
| Cooper (COO) | United States | $15.229B | 24.87 |
| West Pharmaceutical Services (WST) | United States | $10.911B | 46.82 |
| Henry Schein (HSIC) | United States | $10.187B | 18.97 |
| CONMED (CNMD) | United States | $3.236B | 45.97 |
| Patterson (PDCO) | United States | $2.250B | 16.67 |
| STAAR Surgical (STAA) | United States | $1.662B | 86.79 |
| Merit Medical Systems (MMSI) | United States | $1.609B | 18.80 |
| Atrion (ATRI) | United States | $1.310B | 36.09 |
| Antares Pharma (ATRS) | United States | $0.798B | 489.00 |
| Invacare (IVC) | United States | $0.310B | 0.00 |
| Lifevantage (LFVN) | United States | $0.213B | 23.46 |
| Pro-Dex (PDEX) | United States | $0.063B | 17.07 |
| Endologix (ELGX) | United States | $0.042B | 0.00 |
| Biolase (BIOL) | United States | $0.016B | 0.00 |
